AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Capstone Holding Corp. Director's Dealing 2011

Jan 18, 2011

35323_dirs_2011-01-18_685b248f-89ce-47b7-baa5-07b5743371a8.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Capstone Therapeutics Corp. (CAPS)
CIK: 0000887151
Period of Report: 2011-01-17

Reporting Person: HOLLIMAN JOHN M III (Director, Executive Chairman)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2011-01-17	Common Stock	A	50000	—	Acquired	322614	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1568	Indirect
Common Stock	3000	Indirect

Footnotes

F1: Represents 50,000 shares of restricted stock issued pursuant to the Capstone Therapeutics Corp. 2005 Equity Incentive Plan, which are subject to a risk of forfeiture until vesting on 1-17-2012.